Effects of β-blockers on glucose and lipid metabolism

Structured PICO

Do vasodilating beta-blockers improve glucose and lipid metabolism and reduce coronary artery disease risk in high-risk patients with hypertension?

Population

high-risk patients with hypertension

Intervention

vasodilating beta-blockers

Outcome

glucose and lipid metabolismsurrogate

Vasodilating beta-blockers may offer metabolic benefits that could reduce coronary artery disease risk in high-risk hypertensive patients.

Abstract

Improvements in glucose and lipid metabolism mediated by vasodilating beta-blockers may help reduce coronary artery disease risk among high-risk patients with hypertension.

Mark Helpful

Bookmark

Relay

Cite This Study

Vivian Fonseca (Wed,) studied this question.

synapsesocial.com/papers/69d9f5890f32475823a3cb07 https://doi.org/https://doi.org/10.1185/03007990903533681

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Mark Helpful

Bookmark

Relay